<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun C</submitter><funding>Guizhou Provincial Natural Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Science and Technology Planning Project of Guizhou Province</funding><pagination>1474</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9686669</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(11)</volume><pubmed_abstract>The biofilm formation of &lt;i>C. albicans&lt;/i> represents a major virulence factor during candidiasis. Biofilm-mediated drug resistance has necessitated the search for a new antifungal treatment strategy. In our previous study, a novel antimicrobial peptide named AMP-17 derived from &lt;i>Musca domestica&lt;/i> was confirmed to have significant antifungal activity and suppress hyphal growth greatly in &lt;i>C. albicans&lt;/i>. In the current work, we aimed to investigate the antibiofilm property of AMP-17 in &lt;i>C. albicans&lt;/i> and explore the underlying mechanism. An antifungal susceptibility assay showed that AMP-17 exerted a strong inhibitory efficacy on both biofilm formation and preformed biofilms in &lt;i>C. albicans&lt;/i>. Furthermore, AMP-17 was found to block the yeast-to-hypha transition and inhibit </pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pubmed_title>The Antimicrobial Peptide AMP-17 Derived from &lt;i>Musca domestica&lt;/i> Inhibits Biofilm Formation and Eradicates Mature Biofilm in &lt;i>Candida albicans&lt;/i>.</pubmed_title><pmcid>PMC9686669</pmcid><funding_grant_id>ZK[2022] general project 345</funding_grant_id><funding_grant_id>(ZK[2022] Key Program 039)</funding_grant_id><funding_grant_id>82002180</funding_grant_id><funding_grant_id>82060381</funding_grant_id><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Guo G</pubmed_authors><pubmed_authors>Huang M</pubmed_authors><pubmed_authors>Tian C</pubmed_authors><pubmed_authors>Jiao Z</pubmed_authors><pubmed_authors>Peng J</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Antimicrobial Peptide AMP-17 Derived from &lt;i>Musca domestica&lt;/i> Inhibits Biofilm Formation and Eradicates Mature Biofilm in &lt;i>Candida albicans&lt;/i>.</name><description>The biofilm formation of &lt;i>C. albicans&lt;/i> represents a major virulence factor during candidiasis. Biofilm-mediated drug resistance has necessitated the search for a new antifungal treatment strategy. In our previous study, a novel antimicrobial peptide named AMP-17 derived from &lt;i>Musca domestica&lt;/i> was confirmed to have significant antifungal activity and suppress hyphal growth greatly in &lt;i>C. albicans&lt;/i>. In the current work, we aimed to investigate the antibiofilm property of AMP-17 in &lt;i>C. albicans&lt;/i> and explore the underlying mechanism. An antifungal susceptibility assay showed that AMP-17 exerted a strong inhibitory efficacy on both biofilm formation and preformed biofilms in &lt;i>C. albicans&lt;/i>. Furthermore, AMP-17 was found to block the yeast-to-hypha transition and inhibit </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-18T17:08:07.131Z</modification><creation>2025-04-07T04:43:26.117Z</creation></dates><accession>S-EPMC9686669</accession><cross_references><pubmed>36358129</pubmed><doi>10.3390/antibiotics11111474</doi></cross_references></HashMap>